Site MapPagesHomeBrain Tumor StoriesE-NewsletterIt’s personalIvy BlogIvy Center RetreatIvy Center RetreatPhysiciansSupportThe Destination for Brain Tumor Clinical TrialsTrial EligibilityThe ChallengeCurrent Standard of CareConventional Clinical TrialsPhase 0 Clinical TrialsWhy Ivy Clinical Trials?What We TreatHigh-Grade Glioma and Glioblastoma Clinical TrialsClinical Trials for Brain Metastases TreatmentClinical Trials for Recurrent MeningiomaRecurrent Anaplastic Ependymoma Clinical TrialsRecurrent Craniopharyngioma Clinical TrialsClinical Trials for Pineal-Region TumorsCurrent Clinical TrialsInfigratinib in Recurrent Glioblastoma PatientsLy3214996 plus abemaciclib for glioblastomaPamiparib for newly diagnosed or recurrent glioblastomaSonodynamic Therapy in Recurrent High-Grade GliomaPatientsPatient StoriesWhat to ExpectPlan Your VisitCOVID-19 InformationLodgingTransportationPatient SupportFAQsResearchScientific CoresLaboratoriesMehta LaboratoryTovmasyan LaboratoryTien LaboratoryMirzadeh LaboratoryCertificationsPreclinical WorkIndustry CollaborationPublished ResearchAboutTeamAdministrationBusiness OperationsClinical OperationsCommunicationsPreclinical and Translational ScienceBarrow Neurological InstituteThe Ben and Catherine Ivy FoundationNewsroomEventsCareersContact Us
